Home › Funds › ADAMSBROWN WEALTH CONSULTANTS LLC › PPH
ADAMSBROWN WEALTH CONSULTANTS LLC position in PPH
VANECK PHARMACEUTICAL ETF
ADAMSBROWN WEALTH CONSULTANTS LLC reported holding 101,704 shares of PPH (VANECK PHARMACEUTICAL ETF) in its Q3 2026 13F filing — a position valued at US$11.1M, representing 2.03% of its reported portfolio and ranking #15 among its reported holdings. ADAMSBROWN WEALTH CONSULTANTS LLC has disclosed PPH holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How ADAMSBROWN WEALTH CONSULTANTS LLC's PPH position evolved
ADAMSBROWN WEALTH CONSULTANTS LLC first disclosed a stake in PPH in Q3 2024 at 73,972 shares (US$7.0M). The position peaked in Q2 2025 at 195,976 shares, worth US$17.2M. Across 9 filings, ADAMSBROWN WEALTH CONSULTANTS LLC increased the stake 6 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 101,704 shares valued at US$11.1M — a reduction of -52,410 shares quarter over quarter.. Notable position changes include a 102% increase in Q4 2024 (shares rose 6% over the following quarter), a 30% trim in Q3 2025 (shares rose 14% over the following quarter), a 34% trim in Q3 2026 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 73.97K | $7.03M | New |
| Q4 2024 | 149.63K | $12.91M | Add |
| Q1 2025 | 174.90K | $15.94M | Add |
| Q2 2025 | 195.98K | $17.24M | Add |
| Q3 2025 | 136.90K | $12.37M | Reduce |
| Q4 2025 | 143.04K | $14.76M | Add |
| Q1 2026 | 148.81K | $15.46M | Add |
| Q2 2026 | 154.11K | $16.85M | Add |
| Q3 2026 | 101.70K | $11.13M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PPH and 13F data
PPH (VANECK PHARMACEUTICAL ETF) is a company whose sector is not yet classified in our data. 20 other funds we track also report a position in PPH — the largest reported positions include J.Safra Asset Management Corp (US$35.9M), Avalon Trust Co (US$27.8M), Rye Brook Capital LLC (US$7.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PPH
- J.Safra Asset Management Corp 328.31K sh · $35.94M · Q3 2026
- Avalon Trust Co 254.16K sh · $27.82M · Q3 2026
- Rye Brook Capital LLC 70.25K sh · $7.69M · Q3 2026
- WT Wealth Management 47.80K sh · $5.23M · Q3 2026
- Fortis Group Advisors, LLC 31.59K sh · $3.77M · Q3 2026
- Fluent Financial, LLC 26.90K sh · $2.94M · Q3 2026
More on ADAMSBROWN WEALTH CONSULTANTS LLC
FAQ
How long has ADAMSBROWN WEALTH CONSULTANTS LLC held PPH?
ADAMSBROWN WEALTH CONSULTANTS LLC has disclosed PPH holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is ADAMSBROWN WEALTH CONSULTANTS LLC's current position in PPH?
As of Q3 2026, ADAMSBROWN WEALTH CONSULTANTS LLC holds 101.70K shares of PPH (VANECK PHARMACEUTICAL ETF), valued at $11.13M, representing 2.03% of its reported portfolio and ranking #15.
Has ADAMSBROWN WEALTH CONSULTANTS LLC been buying or selling PPH?
In the latest 13F filing (Q3 2026), ADAMSBROWN WEALTH CONSULTANTS LLC reduced its position in PPH. The position peaked in Q2 2025 at 195.98K shares.
Which other funds hold PPH?
Other major institutional holders of PPH include J.Safra Asset Management Corp, Avalon Trust Co, Rye Brook Capital LLC, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.